Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Myriad Genetics (MYGN) Interest & Investment Income (2016 - 2026)

Myriad Genetics has reported Interest & Investment Income over the past 17 years, most recently at $800000.0 for Q4 2025.

  • Quarterly Interest & Investment Income rose 166.67% to $800000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 5.88% year-over-year, with the annual reading at $1.8 million for FY2025, 5.88% up from the prior year.
  • Interest & Investment Income was $800000.0 for Q4 2025 at Myriad Genetics, up from $500000.0 in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $1.1 million in Q3 2022 and troughed at $100000.0 in Q4 2021.
  • The 5-year median for Interest & Investment Income is $400000.0 (2022), against an average of $465000.0.
  • Year-over-year, Interest & Investment Income plummeted 85.71% in 2021 and then skyrocketed 900.0% in 2022.
  • A 5-year view of Interest & Investment Income shows it stood at $100000.0 in 2021, then skyrocketed by 900.0% to $1.0 million in 2022, then decreased by 30.0% to $700000.0 in 2023, then plummeted by 57.14% to $300000.0 in 2024, then skyrocketed by 166.67% to $800000.0 in 2025.
  • Per Business Quant, the three most recent readings for MYGN's Interest & Investment Income are $800000.0 (Q4 2025), $500000.0 (Q3 2025), and $200000.0 (Q2 2025).